Clinical Trial

Improving Hypertension Control in Safety-Net Settings: The Boston Hypertension Equity Alliance in Treatment

Study acronym: BHEAT
Recruiting
View on ClinicalTrials.gov →
Summary
High blood pressure (BP) or hypertension (HTN) affects over 100 million individuals in the US, increasing the risk of adverse outcomes, including stroke, myocardial infarction (MI), and chronic kidney disease (CKD). Effective therapies include non-pharmacologic approaches and multiple medication classes. Successful HTN management requires ongoing patient engagement for BP monitoring and treatment intensification. Reaching this goal is challenging, and many patients with HTN do not have controlled BP. Using a collaborative partnership between patients, clinicians, health system and public health stakeholders, and the research team the investigators plan to overcome barriers to widespread implementation of evidence-based health system strategies to improve BP control in a large, urban, primary care-based safety-net setting for diverse populations experiencing disparities in HTN-related outcomes.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-04-21.
Status change: Not Yet Recruiting → Recruiting 2025-10-09
Trial Details
NCT Number NCT06948838
Lead Sponsor Boston Medical Center
Collaborators: Patient-Centered Outcomes Research Institute, Boston Healthcare for the Homeless Program (BHCHP), Boston Medical Center General Internal Medicine primary care (BMC GIM), Boston Medical Center Family Medicine Primary Care (BMC FM), NeighborHealth Center Family Medicine at Maverick Street (NH FM), NeighborHealth Center Internal Medicine at Gove Street (NH IM), NeighborHealth South End (NH South End), Manet Community Health Center (Maner CHC), Mattapan Community Health Center (Mattapan), Greater Roslindale Medical and Dental Center (GRMDC), Boston University School of Public Health (BUSPH), BUSPH Biostatistics and Epidemiology Data Analytics Center (BEDAC)
Conditions Hypertension, Hypertension Complicated
Enrollment 16,895 participants
Start Date 2025-09-08
Primary Completion 2029-09 (estimated)
Study Completion 2029-09 (estimated)
Updated on ClinicalTrials.gov 2025-10-14